Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep227 | Bone & Osteoporosis | ECE2017

Bone remodeling markers predict bone loss in premenopausal women

Buey Gala Gutierrez , Botella Sonsoles , Restituto Patricia , Fraile Macarena Rodriguez , Calleja Amparo , Llavero Maria , Gargallo Javier , Perdomo Carolina , Andrada Patricia , Varo Nerea , Galofre Juan C

Aim: Bone turnover markers (BTMs) predict more rapid rates of bone loss. However, most of these studies have been carried out in postmenopausal women. Few prospective studies have examined the degradation marker C-terminal telopeptide of type I collagen (CTX) and the bone formation marker N-aminoterminal propeptide of type I collagen (P1NP) measured during the menopausal transition to predict the subsequent bone loss.Methods: We performed a prospective c...

ea0049ep390 | Clinical case reports - Thyroid/Others | ECE2017

Resistant hypertension in an obese type 2 diabetic male with obstructive sleep apnea: resolution with CPAP, weight loss and Dulaglutide

Arnas-Leon Claudia , Santana-Suarez Ana Delia , Rodriguez-Perez Alba , Nivelo-Rivadaneira Manuel , Kuzior Agnieszka , Quintana-Arroyo Sara , Acosta-Calero Carmen , Martinez-Martin Francisco Javier

A 49-year-old male was referred to our Hypertension Clinic with uncontrolled hypertension, treatment Valsartan/Amlodipine/Hydrochlorothiazide 80/10/25 mg + Doxazosine 4 mg. Mean home BP was 156/103 mmHg. Personal history: dyslipidaemia, central obesity and type 2 diabetes, with mild diabetic retinopathy, persistent microalbuminuria and preserved renal function. Treatment: Metformin/Sitagliptin 1000/50 mg BID; Pravastatin/Fenofibrate 40/160 mg. Height 172 cm, weight 112 kg, BMI...

ea0049ep456 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Response to stroke in diabetic versus non-diabetic patients. Should Diabetes education systematically include advise on stroke symptoms and the correct response to them?

Gonzalez-Lazaro Paloma , Silva-Fernandez Julia , Garcia-Ruiz Rafael , Garcia-Ruiz Rosa , Gomez-Alfonso Francisco Javier , Del Val-Zaballos Florentino , Torres-Arroyo Belvis , Gonzalez-Pereira Carolina

Introduction: Stroke is the second cause of death in the world and the first cause of disability. It is also the second cause of Diabetes-related death. The success of reperfusion therapies is time-dependent, with most delays being patient-related. We investigated the response to stroke in diabetic patients (DM), as their risk of stroke is increased by 1,8-6 times.Material and Methods: Consecutive patients with acute stroke or transient ischemic attack w...

ea0049ep472 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Dysregulation of the splicing machinery could represent an early, predictive event in the development of type 2 diabetes

Alors-Perez Emilia , Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Camargo Antonio , Delgado-Lista Javier , Lopez-Miranda Jose , Gahete Manuel D , Castano Justo P , Luque Raul M

Metabolic syndrome (MetS) and type-2 diabetes (T2D) development is critically affected by the loss of phenotypic flexibility (i.e. the difficulty to cope with stressors to maintain metabolic homeostasis). Thus, it is essential to identify key modifiers of phenotypic plasticity that define individual susceptibility to develop T2D. Particularly, there is emerging evidence that alternative mRNA splicing is dysregulated under adverse metabolic-conditions, such as T2D, in several t...

ea0049ep530 | Diabetes complications | ECE2017

Renal function preservation with Manidipine vs Amlodipine in type 2 diabetic hypertensive patients with persistent microalbuminuria

Quintana-Arroyo Sara , Acosta-Calero Carmen , Arnas-Leon Claudia , Santana-Suarez Ana Delia , Kuzior Agnieszka , Saiz-Satjes Margarita , Nivelo-Rivadeneira Manuel , Martinez-Martin Francisco Javier

Objectives: The AMANDHA randomized study (PROBE design) showed that the addition of Manidipine 20 mg vs Amlodipine 10 mg for 2 years in 91 hypertensive type 2 diabetic patients with persistent microalbuminuria, uncontrolled with a renin-angiotensin system inhibitor (given full-dose for at least the 6 previous months) was more effective in reducing albuminuria in spite of similar blood pressure control. Patients with significant renal impairment (PlCr >1.4 mg/dl in women an...

ea0049ep530 (1) | Diabetes complications | ECE2017

Renal function preservation with Manidipine vs Amlodipine in type 2 diabetic hypertensive patients with persistent microalbuminuria

Quintana-Arroyo Sara , Acosta-Calero Carmen , Arnas-Leon Claudia , Santana-Suarez Ana Delia , Kuzior Agnieszka , Saiz-Satjes Margarita , Nivelo-Rivadeneira Manuel , Martinez-Martin Francisco Javier

Objectives: The AMANDHA randomized study (PROBE design) showed that the addition of Manidipine 20 mg vs Amlodipine 10 mg for 2 years in 91 hypertensive type 2 diabetic patients with persistent microalbuminuria, uncontrolled with a renin-angiotensin system inhibitor (given full-dose for at least the 6 previous months) was more effective in reducing albuminuria in spite of similar blood pressure control. Patients with significant renal impairment (PlCr >1.4 mg/dl in women an...

ea0049ep544 | Diabetes complications | ECE2017

Predictor factors of hypertension induced in pregnancy in patients with gestacional diabetes mellitus

Sanchez-Lechuga Begona , Lopez-Tinoco Cristina , Caro Antonio Campos , Martin Raquel De la Varga , Gavira Isabel Mateo , Lopez Francisco Javier Vilchez , Diosdado Manuel Aguilar

Gestational diabetes mellitus (GDM) is associated with an increased risk of pregnancy-induced hypertension (PIH). Ambulatory blood pressure monitoring (ABPM) has been used to screen for PIH and preeclampsia. To date, there are no data regarding ABPM in women with GDM. Currently, little is known in GDM about the role of inflammatory biomarkers in PIH development and their impact on perinatal morbility and the risk of future complications. With this study we aim to identify, in ...

ea0049ep621 | Diabetes therapy | ECE2017

Dulaglutide added on Empagliflozin improves blood pressure, body weight, glycemic control and albuminuria in obese diabetic patients

Acosta-Calero Carmen , Arnas-Leon Claudia , Santana-Suarez Ana Delia , Nivelo-Rivadeneira Manuel , Kuzior Agnieszka , Quintana-Arroyo Sara , Sablon-Gonzalez Nery , Martinez-Martin Francisco Javier

Objective: GLP-1 receptor agonists and SGLT2 inhibitors improve glycemic control, body weight, blood pressure and albuminuria by different pathways. However, their combination is not endorsed by ADA-EASD guidelines, and available data are scarce. Our objective in this open observational study was to elucidate the effect of added Dulaglutide in obese type 2 diabetic patients previously treated with Empagliflozin but insufficiently controlled.Methods: Dula...

ea0049ep757 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Renal function preservation with Manidipine vs Amlodipine in type 2 diabetic hypertensive patients with persistent microalbuminuria

Quintana-Arroyo Sara , Arnas-Leon Claudia , Santana-Suarez Ana Delia , Nivelo-Rivadeneira Manuel , Kuzior Agnieszka , Acosta-Calero Carmen , Saiz-Satjes Margarita , Martinez-Martin Francisco Javier

Objectives: The AMANDHA randomized study (PROBE design) showed that the addition of Manidipine 20 mg vs Amlodipine 10 mg for 2 years in 91 hypertensive type 2 diabetic patients with persistent microalbuminuria, uncontrolled with a renin-angiotensin system inhibitor (given full-dose for at least the 6 previous months) was more effective in reducing albuminuria in spite of similar blood pressure control. Patients with significant renal impairment (PlCr >1.4 mg/dl in women an...

ea0041ep624 | Endocrine tumours and neoplasia | ECE2016

Inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing’s syndrome

Sanchez Beatriz Lardies , Aznar Pablo Trincado , Fernandez Leticia Perez , Monreal Isabel Azcona , Garcia Maria Martinez , Sanz Guayente Verdes , Paris Alejandro Sanz , Perez Javier Acha

Introduction: Bilateral sampling of the inferior petrosal sinuses is an accurate test to diagnose Cushing’s disease and distinguish it with the ectopic ACTH syndrome. The aim of the study was to review the petrosal sinus samplings carried out during last 10 years in our hospital.Methods and material: The medical histories of patients admitted for suspected Cushing’s disease in the last 10 years (from 2005 till 2015) were reviewed. There were se...